
FDA advisory panel narrowly rejects compounding of one peptide, backs two others
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQMGhQZ0lpTHpic0VKbndwZjR6cnJNeEVTaGQyLURIZ3dIUDg5MWNsN21TQk1xTk5CTVgwV20xVnBFUHRjX3JUajdTMkI0bnU3QUlWVVBiNFgzU2pCQy12ODBzQzlPUUF3cExyTUlBOVVubk1nVnNsbk9CSUMtNWtqZ3QyRnllRFEzaWxBSzB4OUJwWHNKTmswU016NElNZFpUdnc?oc=5" target="_blank">FDA advisory panel narrowly rejects compounding of one peptide, backs two others</a>&nbsp;&nbsp;<font color="#6f6f6f">STAT</font>

